• 제목/요약/키워드: Gene and cell therapy

검색결과 454건 처리시간 0.023초

지방유래 줄기세포의 생존능 향상을 위한 CEACAM 6의 생물학적 기능에 대한 연구 (Biological Function of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 for the Enhancement of Adipose-Derived Stem Cell Survival against Oxidative Stress)

  • 고은영;유지은;정세화;김평환
    • 대한임상검사과학회지
    • /
    • 제51권4호
    • /
    • pp.475-483
    • /
    • 2019
  • 세포기반 치료제에 사용되는 줄기세포는 재생능력과 다양한 세포로의 분화능력으로 인해 재생 의학 분야에서 광범위하게 관심을 끌었으며, 많은 불치병에 적용된다. 하지만, 이러한 줄기세포는 여전히 치료 전 세포증식 및 질병 투여부위에서의 낮은 생존률로 인해 충분한 치료효과가 나타나지 않는 단점이 있다. 이것을 해결하고자, 우리는 세포부착능과 항세포자살 기능을 가지고 있는 carcinoembryonic antigen (CEA) gene family의 하나인 CEACAM 6를 사용하였다. 이것을 줄기세포에 적용 전, 먼저 세포별로 이 단백질이 발현되는지를 확인하였고, 이 유전자가 발현되는 벡터를 줄기세포에 삽입시키기 위한 최적 조건을 선정하였다. 그 후, 도입된 CEACAM 6발현벡터로부터 줄기세포에서 이 유전자가 발현되는지를 확인하였다. 그리고 인체투여 시 발생되는 산화적 스트레스와 유사한 조건에서의 이 유전자의 기능을 평가하기 위해 과산화수소(H2O2)를 처리하였다. 산화적 스트레스 조건하에서 CEACAM 6가 발현되는 줄기세포는 그렇지 않은 세포에 비해 세포의 생존률이 현저히 증가하는 것을 확인하였다. 이를 통해, 이 CEACAM 6는 줄기세포의 치료효능과 세포증식을 강화시킬 수 있는 다른 선택지로서의 가능성이 있음을 확인하였다.

Epidermal Growth Factor Receptor Gene Polymorphisms and Gastric Cancer in Iran

  • Abediankenari, Saeid;Jeivad, Fereshteh
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권5호
    • /
    • pp.3187-3190
    • /
    • 2013
  • Background: Epidermal growth factor receptor (EGFR) is a transmembrane receptor which contributes to many processes involved in cell survival, proliferation and inhibits apoptosis, that may lead to cancer development. Gastric cancer is one of the most common diseases of digestive system that has low 5-year-survival. The aim of this research was to determine the significance of EGFR tyrosine kinase domain gene polymorphisms in gastric cancer in Iran. Materials and Methods: In the present study, 83 patients with gastric cancer and 40 normal subjects were investigated for EGFR gene polymorphisms in exons 18-21 by PCR-SSCP. Then, DNA sequencing was conducted for different mobility shift bands. Finally the data were statistically analyzed using the chi-2 test and the SPSSver.16 program. Results: Exon 18 of EGFR gene showed three different bands in SSCP pattern and DNA sequencing displayed one mutation. SSCP pattern of Exons 19 and 21 did not show different migration bands. Exon 20 of EGFR gene revealed multiple migrate bands in SSCP pattern. DNA sequencing displayed 2 mutations in this exon: one mutation was caused amino acid change and another mutation was silent. Conclusion: It may be that EGFR tyrosine kinase gene polymorphisms differ between populations and screening could be useful in gastric cancer patients who might benefit from tyrosine kinase inhibitor therapy.

단순 헤르페스 제 1형 티미딘 키나제 유전자 이입 간암세포주에서 방사표지 IVDU와 IVFRU의 섭취 평가 (In Vitro Uptakes of Radiolabeled IVDU and IVFRU in Herpes Simplex Virus Type-1 Thymidine Kinase (HSV1-tk) Gene Transduced Morris Hepatoma Cell Line)

  • 이태섭;최태현;안순혁;우광선;정위섭;권희충;오옥두;최창운;임상무
    • 대한핵의학회지
    • /
    • 제38권1호
    • /
    • pp.62-73
    • /
    • 2004
  • 목적: 단순 헤르페스 제 1형 티미딘 키나제(herpes simplex virus type 1 thymidine kinase gene: HSV1-tk)는 GCV와 함께 유전자치료의 한 방법으로서 가장 활발하게 연구되어왔으며, HSV1-tk 효소에 대한 다양한 기질들이 연구되어서 이를 보고 기질로 한 비침습적인 HSV1-tk 유전자 영상시스템에서 가장 널리 사용되고 있다. 본 연구에서는 보고기질로서 방사성 요오드가 표지된 5-iodovinyl-2-deoxyuridine (IVDU) and 5 -iodovinyl-2-fluoro-2-deoxyuridine (IVFRU)를 보고 기질로 하여 HSV1-tk 유전자 영상시스템에서의 유용성을 확인하고자 하였다. 대상 및 방법 HSV1-tk 유전자 영상을 위하여 HSV1-tk 유전자를 레트로 바이러스 벡터를 이용하여 Morris hepatoma 세포주(MCA-tk)에 이입한 세포주를 제조하였으며, HSV1-tk 유전자의 발현을 확인하기 위하여 Northern blotting과 Western Blotting을 시행하였다. 대조세포주인 MCA와 제조된 MCA-tk 세포주에 방사표지 IVDU와 IVFRU를 이용하여 480분까지 세포내 섭취율을 평가하였으며, 또한 MCA-tk 세포주의 백분율을 증가시키면서 이에 따른 IVDU와 IVFRU의 섭취율을 평가함으로서 섭취율과 세포수와의 상관관계를 평가하였다. 결과: MCA-tk 세포주에서 HSV1-tk의 mRNA의 발현과 HSV1-TK 단백질의 발현을 확인하였다. 방사성 요오드 표지 IVDU와 IVFRU 모두는 MCA 세포주에서는 아주 낮은 섭취율을 나타내었으며, MCA-tk 세포주에서는 모두 증가된 섭취를 보였다. IVDU가 480분에서 IVFRU보다 4배 높은 섭취를 나타내었다(p<0.01). 방사표지 IVDU와 IVFRU 모두에서 MCA-tk의 백분율의 증가에 따라서 직선적인 상관관계($R^2>0.96$)를 나타내었다. 결론: 방사성 요오드 표지 IVDU와 IVFRU는 HSV1-tk유전자가 이입된 간암세포주에서 모두 특이적인 높은 섭취율을 나타내고 직선적인 상관관계가 나타나서 두 기질 모두 HSV1-tk유전자 영상시스템에서 보고 기질로서 유용하게 사용될 수 있을것으로 기대된다.

운동이 유전자 조절물질에 미치는 영향에 관한 고찰 (A Review : On Exercise Performance Induction Gene Factors Change)

  • 엄기매;양윤권;김태우
    • 대한물리치료과학회지
    • /
    • 제8권1호
    • /
    • pp.745-758
    • /
    • 2001
  • The purpose of study to phenomenological examine and the mechanism regarding the gene(DNA, RNA, Protein) and sports to studied, analyzed. and evaluated. This review considers the evidence for genetic effects in several determinants of endurance performance and resistance performance, namely: body measurements and physique, body fat pulmonary functions, cardiac and circulatory functions, muscle characteristics. substrate utilization, maximal aerobic power and other. Moreover, the response to aerobic training of indicators aerobic work metabolism and endurance performance is reviewed, with emphasis on the specificity of the response and the individual differences observed in training ability. This study indicate that improvement of 'Enhancer Action' in RNA genes changed by exercise or sports. Moreover exercise was effect on Central Dogma with DNA makes RNA makes Protein. and think that occurred with exercise influence on skeletal muscle into cell have to Myosin Heavy Chain (MHC) changed was after exercise performance, which accompanied into skeletal muscle that were exercise-induces gene-modulation that is, take gene mutations. This study known that existed hormone(epinephrine)-immune system with interaction. Exercise were altered insulin binding and MAP Kinase signaling increased into immune cells. This review suggested that the high rate of glutamine utilization by cells of the immune system serves to maintain a high intra cellular concentration of the intermediates of biosynthetic pathways such that optimal rates of DNA, RNA and protein synthesis can be maintained. In the absence of glutamine, lymphocytes do not proliferate in vitro: proliferation increase greatly as the glutamine concentration increase. Glutamine is synthesized in skeletal muscle. Skeletal muscle and plasma glutamine levels are lowered by sepsis, injury, bums, surgery and endurance exercise and in the overtrained athlete. The study of result show that production of ET-1 is markedly increased tissue specifically in the heart by exercise without appreciable changes in endothelin-converting enzyme and endothelial receptor expressions, suggest that myocardial ET-1 may participate in modulation of cardiac function during exercise. Conclusionally, this study indicate that improvement of 'Enhancer Action' in RNA genes changed by exercise or sports. Moreover exercise was effect on Central Dogma with DNA makes RNA makes Protein. This study is expected to contribute the area of sports science, medicine, hereafter more effort is required to establish the relation between gene alters and exercise amount.

  • PDF

다양한 adeno-associated virus (AAV) 혈청형의 효율성 높은 생산법과 새로운 공통적 정량법 개발 (Improved Production Efficiencies of Various Adeno-Associated Virus (AAV) Serotypes and a Novel Universal AAV Titration Method)

  • 조영화;최예진;윤정희;김남희;최미라;최영국;김경희;이영일;이범준;박기랑
    • 생명과학회지
    • /
    • 제22권6호
    • /
    • pp.703-712
    • /
    • 2012
  • AAV는 매우 안전하고 효율적인 유전자전달방법으로 인정되어 왔다. 그러나, AAV가 가진 생물의약품으로서 단점은 효율적이고 재현성 높은 생산법이 취약하고, 또한 다양한 혈청형을 간단한 한 가지 공통적 방법으로 신뢰성 있게 정량하는 방법이 개발되어야 하는 것이다. 따라서, 본 연구에서는 AAV2와 아데노바이러스를 동시에 감염하는 종래의 생산법에 의한 효율성과 새로운 생산법, 즉 AAV2 감염 후 pHelper 플라스미드를 transfection 하는 방법을 통한 생산효율성을 비교하였고, HEK293과 293T를 생산세포주로 하여 시간에 따른 생산효율성도 분석하였다. 그 결과 AAV2와 pHelper DNA를 포함한 새로운 생산법은 기존의 방법에 비해 10배 이상 높은 생산효율성을 보였고, 293T에서 AAV2를 10 MOI로 감염한 후 5일째에 가장 높은 생산효율성을 보였는데, 생산세포 한 개 당 $1.61{\times}10^5$ virus genomes (v.g.)을 생산하는 결과였다. 따라서 이 생산조건을 다른 혈청형 생산에 적용한 결과, 모든 혈청형에서 생산세포주 한 개 당 $10^5$ v.g. 이상을 생산하는 효율성을 보였다. 한편, 다양한 AAV 혈청형을 한 가지 공통적인 방법으로 정량하기 위해 the universal PCR 프라이머를 제작하였고, 그것을 이용하여 신뢰성 높고 10개 분자까지도 증폭이 가능한 결과를 모든 혈청형에서 얻었다. 그러므로 이 한 쌍의 정량용 the universal 프라이머는 임상시험용 아데노바이러스벡터에 존재하는 AAV오염을 검출하는 것에도 사용 가능하다.

BRCA1 Gene Mutations and Influence of Chemotherapy on Autophagy and Apoptotic Mechanisms in Egyptian Breast Cancer Patients

  • Abdel-Mohsen, Mohamed Ahmed;Ahmed, Omiama Ali;El-Kerm, Yasser Mostafa
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권3호
    • /
    • pp.1285-1292
    • /
    • 2016
  • Background: It is well established that mutations in the BRCA1 gene are a major risk factor for breast cancer. Induction of cancer cell death and inhibition of survival are the main principles of cancer therapy. In this context, autophagy may have dual roles in cancer, acting on the one hand as a tumor suppressor and on the other as a mechanism of cell survival that can promote the growth of established tumors. Therefore, understanding the role of autophagy in cancer treatment is critical. Moreover, defects in apoptosis, programmed cell death, may lead to increased resistance to chemotherapy. Purpose: The aim of the present study was to detect BRCA1 gene mutations in order to throw more light on their roles as risk factors for breast cancer in Egypt. Secondly the role of autophagy and apoptosis in determining response to a fluorouracil, doxorubicin, cyclophosphamide (FAC) regimen was investigated. Materials and Methods: Forty-five female breast cancer cases and thirty apparently healthy females were enrolled in the present study. Serum levels of autophagic biomarkers, Beclin 1 and LC3 as well as the serum levels of apoptosis biomarkers Bcl-2 and Caspase-3 were measured before and after chemotherapy. Results: BRCA1 mutations were found in 5 (16.7%) and 44 (99.8%) of the controls and cancer patients, the most frequent being 5382insC followed by C61G and 185 delAG. The results revealed that chemotherapy caused elevation in serum concentration levels of the autophagic biomarkers (Beclin 1 and LC3). This elevation was associated with a significant decrease in serum concentration levels of Bcl-2 and significant increase in caspase-3 concentration levels (apoptotic markers). Conclusions: The results of the present study indicate a very high level of BRCA mutations in breast cancer cases in Egypt and point to involvement of autophagic and apoptotic machinery activation in response to FAC chemotherapy.

Microarray Analysis of Oxygen-Glucose-Deprivation Induced Gene Expression in Cultured Astrocytes

  • Joo, Dae-Hyun;Han, Hyung-Soo;Park, Jae-Sik
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제10권5호
    • /
    • pp.263-271
    • /
    • 2006
  • Since astrocytes were shown to play a central role in maintaining neuronal viability both under normal conditions and during stress such as ischemia, studies of the astrocytic response to stress are essential to understand many types of brain pathology. The micro array system permitted screening of large numbers of genes in biological or pathological processes. Therefore, the gene expression patterns in the in vitro model of astrocytes following exposure to oxygen-glucose deprivation (OGD) were evaluated by using the micro array analysis. Primary astrocytic cultures were prepared from postnatal Swiss Webster mice. The cells were exposed to OGD for 4 hrs at $37^{\circ}C$ prior to cell harvesting. From the cultured cells, we isolated mRNA, synthesized cDNA, converted to biotinylated cRNA and then reacted with GeneChips. The data were normalized and analyzed using dChip and GenMAPP tools. After 4 hrs exposure to OGD, 4 genes were increased more than 2 folds and 51 genes were decreased more than 2 folds compared with the control condition. The data suggest that the OGD has general suppressive effect on the gene expression with the exception of some genes which are related with ischemic cell death directly or indirectly. These genes are mainly involved in apoptotic and protein translation pathways and gap junction component. These results suggest that microarray analysis of gene expression may be useful for screening novel molecular mediators of astrocyte response to ischemic injury and making profound understanding of the cellular mechanisms as a whole. Such a screening technique should provide insights into the molecular basis of brain disorders and help to identify potential targets for therapy.

NIS 기능의 전사 및 전사외 조절과 방사성옥소 섭취 (Transcriptional and Nontranscriptional Regulation of NIS Activity and Radioiodide Transport)

  • 정경호;이경한
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제41권5호
    • /
    • pp.343-349
    • /
    • 2007
  • 방사성옥소는 갑상선암의 핵의학적 영상과 방사성치료에 널리 그리고 성공적으로 사용되어 왔다. 최근 세포의 옥소섭취를 담당하는 운반체로서 Na/I symporter (NIS)의 분자세포학적 특성이 규명되고 그 유전자가 클로닝되면서 앞으로는 갑상선암 이외의 각종 암에도 NIS 유전자를 외부에서 전달함으로써 방사성옥소 치료를 적용하는 새로운 암치료 기술이 가능할 것으로 기대되고 있다. 방사성옥소를 이용한 암치료의 성공을 위해서는 NIS를 통한 표적세포의 옥소 섭취를 극대화 시키는 것이 핵심이다. TSH는 갑상선 세포의 NIS 발현을 항진시키고 retinoic acid는 갑상선암과 유방암 세포의 NIS발현을 증가시키는 효과가 있다. 또 일반 암세포에는 NIS 유전자를 전달하여 발현 시킬 수 있다. 그러나 NIS 발현 만으로는 원하는 수준의 방사성옥소 섭취를 충분히 얻지 못할 수 있다. 이는 세포의 옥소 섭취가 NIS 단백질의 총량이 아니라 세포막에 위치한 NIS의 양에 의해 결정되기 때문이다. 즉, 옥소를 섭취하려는 전사된 NIS단백질이 세포막으로 이동하여 정상적으로 기능하게 하는 조절 기전이 중요하다. NIS의 세포막 이동 기전은 아직 밝혀져 있지 않으나 다른 운반체와 유사하게 단백질의 전사후 glycosylation이나 phosphorylation이 관여할 것으로 생각된다. 본 연구진은 NIS 유전자를 전달한 암세포에서epidermal growth factor를 통한 extracellular signal regulated kinase 신호경로의 활성화가 방사성옥소 섭취를 항진시킴을 관찰하여 NIS의 전사외 기능조절 기전을 조사하고 있다. 앞으로 NIS기능에 대한 조절기전이 보다 자세하게 밝혀지면 방사성옥소 치료기술과 NIS유전자 영상기술의 개선과 발전에 도움이 될 것으로 기대된다.

A New Method for Transduction of Mesenchymal Stem Cells Using Mechanical Agitation

  • Park, Jin-O;Park, Sung-Hoon;Hong, Seong-Tshool
    • Molecules and Cells
    • /
    • 제28권6호
    • /
    • pp.515-520
    • /
    • 2009
  • Applications of bone marrow-derived mesenchymal stem cells in gene therapy have been hampered by the low efficiency of gene transfer to these cells. In current transduction protocols, retrovirus particles with foreign genes make only limited contact with their target cells by passive diffusion and have short life spans, thereby limiting the chances of viral infection. We theorized that mechanically agitating the virus-containing cell suspensions would increase the movement of viruses and target cells, resulting in increase of contact between them. Application of our mechanical agitation for transduction process has increased the absorption of retrovirus particles more than five times compared to the previous static method without changing cell growth rate and viability. The addition of a mechanical agitation step increased transduction efficiency to 42%, higher than that of any other previously-known static transduction protocol.

MethA Fibrosarcoma Cells Expressing Membrane-Bound Forms of IL-2 Enhance Antitumor Immunity

  • Sonn, Chung-Hee;Yoon, Hee-Ryung;Seong, In-Ock;Chang, Mi-Ra;Kim, Yong-Chan;Kang, Han-Chul;Suh, Seok-Cheol;Kim, Young-Sang
    • Journal of Microbiology and Biotechnology
    • /
    • 제16권12호
    • /
    • pp.1919-1927
    • /
    • 2006
  • Tumor cells genetically engineered to secrete cytokines are effective in tumor therapy, but various unexpected side effects are observed, which may result from the bulk activation of various bystander cells. In this study, we tested tumor vaccines expressing various membrane-bound forms of IL-2 (mbIL-2) on MethA fibrosarcoma cells to focus antitumor immune responses to CTL. Chimeric forms of IL-2 with whole CD4, deletion forms of CD4, and TNF were expressed on the tumor cell surface, respectively. Tumor clones expressing mbIL-2 or secretory form of IL-2 were able to support the cell growth of CTLL-2, an IL-2-dependent T cell line, and the proliferation of spleen cells from 2C TCR transgenic mice that are responsive to the $p2Ca/L^d$ MHC class I complex. Expression of mbIL-2 on tumor cells reduced the tumorigenicity of tumor cells, and the mice that once rejected the live IL-2/TNF tumor clone acquired systemic immunity against wild-type MethA cells. The IL-2/TNF clone was inferior to other clones in tumor formation, and superior in the stimulation of the CD8+ T cell population in vitro. These results suggest that the IL-2/TNF clone is the best tumor vaccine, and may stimulate CD8+ T cells by direct priming. Expression of IL-2/TNF on tumor cells may serve as an effective gene therapy method to ameliorate the side effects encountered in the recombinant cytokine therapy and the conventional cytokine gene therapy using the secretory form of IL-2.